# Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

> **NCT05737602** · NA · ENROLLING_BY_INVITATION · sponsor: **Massachusetts General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Von Hippel-Lindau Disease
- Genetic Disorder

## Interventions

- **BEHAVIORAL:** 3RP-VHL

## Key facts

- **NCT ID:** NCT05737602
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-30
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-05-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737602, "Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05737602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*